Akili Interactive releases a new version of its ADHD treatment game for adults.

Humira biosimilars finally launch on the US market

More pharma stakeholders are launching lawsuits over the US government’s Inflation Reduction Act.

Is safeguard sgRNA the key to reducing the off-target effects of gene editing, while increasing its potential applications?

The case of Kathleen Folbigg shows how far the field has come, but there are still no medical interventions for sudden infant death syndrome.

Are antibody drug conjugates (ADCs) the breakthrough in cancer treatment? Experts share insights on recent advancements

MSD describes drug price negotiation program as “sham” and “tantamount to extortion”

Misbranded drugs, unapproved drugs, and companies who don’t know that ophthalmic drugs should be manufactured in a sterile environment…

Amgen’s planned acquisition of Horizon Therapeutics has hit a bump in the road.

We ask an expert for their top tips for ensuring outsourcing goes smoothly.